SAXAGLIPTIN (SAXAGLIPTIN HYDROCHLORIDE) — all Canadian products
15 DINs
8 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is SAXAGLIPTIN (SAXAGLIPTIN HYDROCHLORIDE), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02507471 | APO-SAXAGLIPTIN | APOTEX INC | Tablet | Oral | SAXAGLIPTIN (SAXAGLIPTIN HYDROCHLORIDE) 2.5 MG | Marketed | |
| 02507498 | APO-SAXAGLIPTIN | APOTEX INC | Tablet | Oral | SAXAGLIPTIN (SAXAGLIPTIN HYDROCHLORIDE) 5 MG | Marketed | |
| 02375842 | ONGLYZA | ASTRAZENECA CANADA INC | Tablet | Oral | SAXAGLIPTIN (SAXAGLIPTIN HYDROCHLORIDE) 2.5 MG | Marketed | |
| 02333554 | ONGLYZA | ASTRAZENECA CANADA INC | Tablet | Oral | SAXAGLIPTIN (SAXAGLIPTIN HYDROCHLORIDE) 5 MG | Marketed | |
| 02524341 | PRO-SAXAGLIPTIN | PRO DOC LIMITEE | Tablet | Oral | SAXAGLIPTIN (SAXAGLIPTIN HYDROCHLORIDE) 5 MG | Approved | |
| 02524333 | PRO-SAXAGLIPTIN | PRO DOC LIMITEE | Tablet | Oral | SAXAGLIPTIN (SAXAGLIPTIN HYDROCHLORIDE) 2.5 MG | Approved | |
| 02468603 | SANDOZ SAXAGLIPTIN | SANDOZ CANADA INCORPORATED | Tablet | Oral | SAXAGLIPTIN (SAXAGLIPTIN HYDROCHLORIDE) 2.5 MG | Marketed | |
| 02468611 | SANDOZ SAXAGLIPTIN | SANDOZ CANADA INCORPORATED | Tablet | Oral | SAXAGLIPTIN (SAXAGLIPTIN HYDROCHLORIDE) 5 MG | Marketed | |
| 02389169 | KOMBOGLYZE | ASTRAZENECA CANADA INC | Tablet | Oral | SAXAGLIPTIN (SAXAGLIPTIN HYDROCHLORIDE) 2.5 MG; METFORMIN HYDROCHLORIDE 500 MG | Cancelled Post Market | |
| 02389177 | KOMBOGLYZE | ASTRAZENECA CANADA INC | Tablet | Oral | SAXAGLIPTIN (SAXAGLIPTIN HYDROCHLORIDE) 2.5 MG; METFORMIN HYDROCHLORIDE 850 MG | Cancelled Post Market | |
| 02389185 | KOMBOGLYZE | ASTRAZENECA CANADA INC | Tablet | Oral | SAXAGLIPTIN (SAXAGLIPTIN HYDROCHLORIDE) 2.5 MG; METFORMIN HYDROCHLORIDE 1000 MG | Cancelled Post Market | |
| 02459183 | QTERN | ASTRAZENECA CANADA INC | Tablet | Oral | SAXAGLIPTIN (SAXAGLIPTIN HYDROCHLORIDE) 5 MG; DAPAGLIFLOZIN (DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE) 10 MG | Cancelled Pre Market | |
| 02459175 | QTERN | ASTRAZENECA CANADA INC | Tablet | Oral | SAXAGLIPTIN (SAXAGLIPTIN HYDROCHLORIDE) 5 MG; DAPAGLIFLOZIN (DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE) 5 MG | Cancelled Pre Market | |
| 02456966 | TEVA-SAXAGLIPTIN | TEVA CANADA LIMITED | Tablet | Oral | SAXAGLIPTIN (SAXAGLIPTIN HYDROCHLORIDE) 2.5 MG | Cancelled Pre Market | |
| 02456974 | TEVA-SAXAGLIPTIN | TEVA CANADA LIMITED | Tablet | Oral | SAXAGLIPTIN (SAXAGLIPTIN HYDROCHLORIDE) 5 MG | Cancelled Pre Market |
Browse other molecules: